Clinical effect of modified Maxing Shigan decoction in the treatment of children with bronchopneumonia

Objective: To explore the clinical effect of applying modified Maxing Shigan decoction in the treatment of children with bronchopneumonia. Methods: The research work was carried out in our hospital from June 2021 to June 2022, and a total of 100 patients were selected as the research objects. The patients were all children with bronchopneumonia, and the selected patients were divided into two groups (based on different treatment methods). Among them, 50 were treated with conventional western medicine (control group), and the other 50 were treated with modified Maxing Shigan decoction (experimental group). The clinical effects of different treatment methods were compared and analyzed. Results: The cough reduction time, the fever subsidence time and the lung rales subsidence time of the children in the experimental group were all shorter than those in the control group, and the recovery speed was faster. All data indicators were statistically different from those in the control group (P <0.05). Moreover, the scores of pulmonary function indexes such as FEV1, FEF and FVC in the experimental group after treatment were lower than those in the control group, and the difference was significant with that in the control group, P<0.05. The treatment effective rate was 98.00% in the experimental group and 84.00% in the control group. There was a significant difference in the effective rate between the two groups, P<0.05, which was statistically significant. Conclusion: The application of Modified Maxing Shigan Decoction in the treatment of children with bronchopneumonia has a significant effect, which can improve the clinical efficiency, improve the lung function of children, and promote the recovery of children, with high application value.